Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Citigroup Inc. 

Silk Road Medical Inc diskutieren

Silk Road Medical Inc

WKN: A2PFG4 / Symbol: SILK / Name: Silk Road Medical Inc / Aktie / Small Cap /

19,70 €
-2,48 %

Einschätzung Buy
Rendite (%) -55,00 %
Kursziel 46,01
Veränderung
Endet am 03.04.24

Silk Road Medical, Inc (NASDAQ: SILK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $50.00 price target on the stock.
Ratings data for SILK provided by MarketBeat

Einschätzung Buy
Rendite (%) -30,82 %
Kursziel 43,65
Veränderung
Endet am 23.05.24

Silk Road Medical, Inc (NASDAQ: SILK) is now covered by analysts at CL King. They set a "buy" rating and a $47.00 price target on the stock.
Ratings data for SILK provided by MarketBeat

Silk Road Medical, Inc (NASDAQ: SILK) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.
Ratings data for SILK provided by MarketBeat

Silk Road Medical, Inc (NASDAQ: SILK) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock.
Ratings data for SILK provided by MarketBeat

Einschätzung Buy
Rendite (%) 91,26 %
Kursziel 18,32
Veränderung
Endet am 03.01.25

Silk Road Medical, Inc (NASDAQ: SILK) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for SILK provided by MarketBeat

Einschätzung Buy
Rendite (%) 52,24 %
Kursziel 18,38
Veränderung
Endet am 19.01.25

Silk Road Medical, Inc (NASDAQ: SILK) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock, up previously from $9.00.
Ratings data for SILK provided by MarketBeat

Einschätzung Buy
Rendite (%) 22,89 %
Kursziel 21,28
Veränderung
Endet am 28.02.25

Silk Road Medical, Inc (NASDAQ: SILK) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for SILK provided by MarketBeat

Einschätzung Buy
Rendite (%) 36,00 %
Kursziel 22,07
Veränderung
Endet am 07.03.25

Silk Road Medical, Inc (NASDAQ: SILK) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock.
Ratings data for SILK provided by MarketBeat